Inventia Life Science and BioLamina partner to advance cell matrices for complex 3D cell models

August 24, 2021 — Inventia Life Science, together with BioLamina AB, a leading Swedish biotechnology company in matrix biology and cell culture-based research, has entered into a partnership to provide 3D cell culture scaffolds, compatible with the RASTRUM™ platform, containing recombinant human laminin proteins (Biolaminin®). As part of this partnership, Inventia Life Science will now offer BioLamina’s wide range of Biolaminin® products for incorporation into the pre-validated library of RASTRUM™ arrays, summarizing key motifs found in the native tissue of various cell types.

Laminins, important proteins found in the extracellular matrix (ECM) and microenvironment of cells and tissues, are generally required by cells for cell differentiation, migration and adhesion. By including laminins in in vitro cellular models, researchers were not only able to mimic the native ECM of various tissues, but also to study the role of different laminin isoforms in disease progression and drug resistance mechanisms.

The partnership with Inventia Life Science is an important step in our ambition to demonstrate the roles of laminins in complex cellular assays. We strive to improve the quality and reliability of 3D cell culture by adding biorelevant biolaminin® for authentic tissue cell responses. The RASTRUM™ platform adds significant customer value as it enables automated workflow. We look forward to continuing the advancements this collaboration can bring,” says Dr. Therese Kallur, Business Development Manager at BioLamina AB.

This new partnership aims to provide next-generation complex 3D cell models incorporating BioLamina’s experience and product portfolio, which has already proven to be of great interest to many researchers, especially those working in oncology. The production of these laminin-containing 3D models can now be achieved in a highly reproducible manner, while being dramatically boosted by the automated and high-throughput capabilities of the popular RASTRUM™ 3D cell culture platform.

A physiologically relevant matrix environment is crucial for our RASTRUM™ 3D cell models to recapitulate diverse cell behaviors and phenotypes. BioLamina’s Biolaminins® enable our RASTRUM™ matrices to better mimic the in vivo microenvironments of the extracellular matrix in a reproducible and tissue-specific way,” says Dr. Robert Utama, Senior Product Manager, Inventia Life Science.

About BioLamina AB

BioLamina AB is a science-based Swedish biotechnology company with a heritage in matrix biology and cell culture-based research. Our flagship products, our biorelevant recombinant human laminin isoforms, Biolaminin®, are defined cell culture matrices that successfully mimic the cell-specific natural cell-matrix interaction in the cell culture dish, allowing cells to thrive and to maintain their function. Our products are a powerful resource for scientists working with stem cells and primary cells both in basic research and in regenerative medicine companies focused on cell therapy applications.

For more information, please contact:
Inventia life sciences
Dr. Duyen Nguyen
E-mail: [email protected]

BIOLAMINA AB
Dr Therese Kalur
E-mail: [email protected] Where [email protected]

Comments are closed.